|
|
Logo
Logo Logo

Category Archives: "Partners"

  1. Home
  2. Partners
  3. Page 12
Apr 12, 2016
New data from three Phase III studies of the medicine OCREVUS™ (ocrelizumab)
Partners
GENENTECH TO PRESENT NEW DATA AT AAN SHOWING SUPERIOR EFFICACY OF NVESTIGATIONAL MEDICINE OCRELIZUMAB VERSUS COMPARATORS ON DISEASE [...]
Elizabeth Porco
Read More
...9
0
Jan 05, 2016
Francois Bethoux, MD, named medical director of the Arts & Medicine Institute
Partners
Iva Fattorini, MD, has stepped down from her role as Global Chair of the Arts & Medicine Institute, effective Jan. 1. Cleveland Clinic [...]
Elizabeth Porco
Read More
...10
0
Dec 26, 2015
National Multiple Sclerosis Society honors physician
Partners
DERBY — Joseph Guarnaccia, M.D., clinical director of the Multiple Sclerosis Treatment Center at Griffin Hospital, was recently inducted [...]
Elizabeth Porco
Read More
...10
0
Dec 20, 2015
MedDay misses endpoint in phase III multiple sclerosis vision loss trial
INforMS, Partners
A Phase III trial of MedDay's multiple sclerosis drug has missed its primary endpoint. The drug, which made headlines in April when it [...]
Elizabeth Porco
Read More
...10
0
Oct 21, 2015
Biogen reports top-line results from phase 3 study evaluating Natalizumab in SPMS
INforMS, Partners
Wednesday, October 21, 2015 7:31 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Phase 3 ASCEND study investigating natalizumab in the [...]
Elizabeth Porco
Read More
...10
0
Oct 12, 2015
EMD Serono announces publication of PRISMS-15 year follow-up study using Rebif in RRMS
INforMS, Partners
Rockland, Massachusetts, October 12, 2015 – EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today [...]
Elizabeth Porco
Read More
...11
0
Oct 08, 2015
Treatment effects maintained over 5 years in patients with RRMS who received Lemtrada
INforMS, Partners
Thursday, October 8, 2015 1:00 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, aSanofi company, today announced positive new [...]
Elizabeth Porco
Read More
...9
0
Oct 08, 2015
Genentech’s Ocrelizumab show positive pivotal study results in both RRMS and PPMS
INforMS, Partners
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive [...]
Elizabeth Porco
Read More
...12
0
Oct 08, 2015
EMD Serono announces recipients of the third annual €1 million grant for multiple sclerosis innovation
INforMS, Partners
EMD Serono Announces Recipients of the Third Annual €1 Million Grant for Multiple Sclerosis Innovation Four research grants awarded [...]
Elizabeth Porco
Read More
...10
0
Oct 07, 2015
New analysis suggests Aubagio slows brain atrophy in people with Relapsing MS
INforMS, Partners
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis Additional MRI data on [...]
Elizabeth Porco
Read More
...10
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last